Phenytoin (Dilantin) induces gingival overgrowth characterized by an accumulation of connective tissue The cell-to-matrix ratio in the mature lesion is normal, yet there must be more fibroblasts per oral cavity if there is excessive tissue mass. Using a mongrel cat model system, we studied the early, developing phenytoin-induced lesion by quantitating fibroblasts per unit of tissue in papilla biopsies collected over a 3-month period of daily drug administration. At 6 and 8 weeks, the number of fibroblasts per unit of tissue increased dramatically. By 3 months, as the lesions matured, the fibroblast-to-matrix ratio returned to normal. We suggest that the drug interacts with resident gingival fibroblasts, causes them to proliferate and thus induces a true, but transient, hypercellularity. Cell division then appears to slow or cease, and rapid production of connective tissue matrix ensues, returning the cell-to-matrix ratio to normal.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-051x.1982.tb02047.xDOI Listing

Publication Analysis

Top Keywords

developing phenytoin-induced
8
gingival overgrowth
8
connective tissue
8
cell-to-matrix ratio
8
fibroblasts unit
8
unit tissue
8
tissue
5
quantitative histopathologic
4
histopathologic assessment
4
assessment developing
4

Similar Publications

Article Synopsis
  • Phenytoin (PHT) is a medication used to treat epilepsy but has a narrow therapeutic window, necessitating careful monitoring to avoid adverse drug reactions (ADRs) like ataxia, which is less commonly reported.* -
  • A case report describes a 16-year-old Asian patient who developed ataxia, giddiness, and vomiting while on Phenytoin and other seizure medications, with MRI revealing brain lesions and toxic serum levels of Phenytoin.* -
  • The patient’s adverse symptoms resolved after discontinuation of Phenytoin and continuation of other medications, highlighting the importance of therapeutic drug monitoring (TDM) to prevent toxicity and promote better treatment outcomes in epilepsy.*
View Article and Find Full Text PDF

 is a first-generation anticonvulsant medicine that efficiently cures a wide range of seizures, including status epilepticus, complex partial seizures, and generalized tonic-clonic seizures (GCTS). The major advantage of phenytoin is that its neurological functions are preserved. Phenytoin works by inhibiting voltage-dependent membrane Na channels, which are essential to generate action potential.

View Article and Find Full Text PDF

Purple glove syndrome (PGS) is a rare condition characterized by limb edema, discoloration, and pain associated with intravenous and oral phenytoin administration. The pathophysiology is poorly understood, and there is no established treatment. Simple cases have previously been managed with hyaluronidase subcutaneous injections, with more severe cases resulting in compartment syndrome, debridement, or even amputation.

View Article and Find Full Text PDF

Phenytoin-induced liver injury (PHT ILII) is a serious condition that may necessitate discontinuation of the drug. This study investigates the mechanisms of PHT ILII and evaluates the protective effects of Balanites Aegyptiaca (BA) fruit extracts on the liver. We focus on the Nrf2/MAPK/NF-κB/Beclin-1 signaling pathways involved in oxidative stress and inflammation from drug-induced liver injury.

View Article and Find Full Text PDF

Background: Dyskinesia is a movement disorder categorized by involuntary movement of muscle. Although dyskinesia can be brought on by taking medications, it can also be a symptom of a variety of diseases. Antiepileptic drug-induced involuntary movements have been well researched.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!